BIVALIRUDIN

Important: Therapy notes

BNF

Important: Formulation and dosage details

Formulation:

Powder for solution for injection 250mg (Hospital use only)

Dosage:

For use in patients with acute coronary syndrome undergoing percutaneous coronary intervention with a higher bleeding risk.

Editorial Information

Document Id: F032